Your browser doesn't support javascript.
loading
Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
Prado, Verónica; Hernández-Tejero, María; Mücke, Marcus M; Marco, Francesc; Gu, Wenyi; Amoros, Alex; Toapanta, David; Reverter, Enric; Peña-Ramirez, Carlos de la; Altenpeter, Laura; Bassegoda, Octavi; Mezzano, Gabriel; Aziz, Fátima; Juanola, Adria; Rodríguez-Tajes, Sergio; Chamorro, Vanessa; López, David; Reyes, Marta; Hogardt, Michael; Kempf, Volkhard A J; Ferstl, Philip G; Zeuzem, Stefan; Martínez, José Antonio; Vila, Jordi; Arroyo, Vicente; Trebicka, Jonel; Fernandez, Javier.
Afiliação
  • Prado V; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain; Hepato-Gastro-enterology Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.
  • Hernández-Tejero M; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Mücke MM; Department for Internal Medicine I, Goethe University Frankfurt, Germany.
  • Marco F; Microbiology Department, Hospital Clinic, University of Barcelona, Spain; ISGlobal, Hospital Clínic - University of Barcelona, Spain.
  • Gu W; Department for Internal Medicine I, Goethe University Frankfurt, Germany.
  • Amoros A; EF Clif, EASL-CLIF Consortium, Barcelona, Spain.
  • Toapanta D; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Reverter E; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Peña-Ramirez C; EF Clif, EASL-CLIF Consortium, Barcelona, Spain.
  • Altenpeter L; Department for Internal Medicine I, Goethe University Frankfurt, Germany.
  • Bassegoda O; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Mezzano G; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Aziz F; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Juanola A; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Rodríguez-Tajes S; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Chamorro V; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • López D; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Reyes M; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain.
  • Hogardt M; Institute of Medical Microbiology and Infection Control, Goethe University Frankfurt, Germany; University Center for Infectious Diseases, University Hospital Frankfurt, Germany; University Center of Competence for Infection Control, State of Hesse, Germany.
  • Kempf VAJ; Institute of Medical Microbiology and Infection Control, Goethe University Frankfurt, Germany; University Center for Infectious Diseases, University Hospital Frankfurt, Germany; University Center of Competence for Infection Control, State of Hesse, Germany.
  • Ferstl PG; Department for Internal Medicine I, Goethe University Frankfurt, Germany.
  • Zeuzem S; Department for Internal Medicine I, Goethe University Frankfurt, Germany.
  • Martínez JA; Infectious Disease Department, Hospital Clinic, Barcelona, Spain.
  • Vila J; Microbiology Department, Hospital Clinic, University of Barcelona, Spain; ISGlobal, Hospital Clínic - University of Barcelona, Spain.
  • Arroyo V; EF Clif, EASL-CLIF Consortium, Barcelona, Spain.
  • Trebicka J; Department for Internal Medicine I, Goethe University Frankfurt, Germany; EF Clif, EASL-CLIF Consortium, Barcelona, Spain.
  • Fernandez J; Liver ICU, Liver Unit, Hospital Clinic, University of Barcelona, IDIBAPS and CIBERehd, Spain; EF Clif, EASL-CLIF Consortium, Barcelona, Spain. Electronic address: Jfdez@clinic.cat.
J Hepatol ; 76(5): 1079-1089, 2022 05.
Article em En | MEDLINE | ID: mdl-35074475
ABSTRACT
BACKGROUND &

AIMS:

It remains unclear whether rectal colonization with multidrug-resistant organisms (MDROs) is prevalent and predisposes to infections by the same pathogens in patients with cirrhosis.

METHODS:

Two series of critically ill patients were evaluated. In the Barcelona cohort, 486 consecutive patients were prospectively evaluated, 129 with and 357 without cirrhosis (2015-2016). Rectal swabs were performed at admission and weekly thereafter (until intensive care unit [ICU] discharge) to detect MDRO colonization. Risk factors for colonization and infection by MDROs were evaluated. A retrospective cohort from Frankfurt (421 patients with cirrhosis; 2010-2018) was investigated to evaluate MDRO rectal colonization in another epidemiological scenario.

RESULTS:

In the Barcelona cohort, 159 patients were colonized by MDROs (32.7%), 102 (64.2%) at admission and 57 (35.8%) during follow-up. Patients with cirrhosis showed higher rates of rectal colonization at admission than those without cirrhosis (28.7% vs. 18.2%, p = 0.01) but similar colonization rates during ICU stay. Extended-spectrum beta-lactamase-Enterobacterales were the most frequent MDROs isolated in both groups. Colonization by MDROs independently increased the risk of infection by MDROs at admission and during follow-up. Risk of new infection by the colonizing strain was also significantly increased in patients with (hazard ratio [HR] 7.41) and without (HR 5.65) cirrhosis. Rectal colonization by MDROs was also highly prevalent in Frankfurt (n = 198; 47%; 131 at admission [66.2%] and 67 [33.8%] during follow-up), with vancomycin-resistant enterococci being the most frequent colonizing organism. Rectal colonization by MDROs was also associated with an increased risk of infection by MDROs in this cohort. Infections occurring in MDR carriers were mainly caused by the colonizing strain.

CONCLUSION:

Rectal colonization by MDROs is extremely frequent in critically ill patients with cirrhosis. Colonization increases the risk of infection by the colonizing resistant strain. LAY

SUMMARY:

Rectal colonization by multidrug-resistant organisms (MDROs) is a prevalent problem in patients with cirrhosis requiring critical care. The pattern of colonizing bacteria is heterogeneous with relevant differences between centers. Colonization by MDROs is associated with increased risk of infection by the colonizing bacteria in the short term. This finding suggests that colonization data could be used to guide empirical antibiotic therapy and de-escalation policies in patients with cirrhosis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Terminal / Staphylococcus aureus Resistente à Meticilina Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Luxemburgo

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Terminal / Staphylococcus aureus Resistente à Meticilina Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Luxemburgo